Written by Beena Thannickal
Yang’s research focuses on a new class of drug – PARP inhibitors – that interfere with a cancer cell’s ability to repair DNA damage, hastening cell death.
Dancers kick up their heels to support research into healthy aging at the fourth annual event.
Drug-eluting stents pose no greater risk of major heart attack following non-cardiac surgery than bare metal stents.
Diana Florence, administrative support specialist in Rheumatology and Osteoporosis, will be honored later this fall for winning the highest non-academic employee award.
Written by Tyler Greer
Patients in estrogen trial had fewer poor results, and in post-intervention there was a significant decrease in breast cancer.